Organization profile

Organization profile

The Cancer Epigenetics Institute (CEI) at Fox Chase is a national hub for epigenetics study and collaboration that is focused on mechanisms promoting cancer and therapeutic resistance. CEI aims to promote fundamental discovery in cancer epigenetics, while identifying novel biomarkers and therapeutic targets. Its mission is to translate these scientific insights into a positive impact on patients by facilitating academic-to-industry and academic-to-academic partnerships. Johnathan R. Whetstine, PhD, leads Fox Chase's Cancer Epigenetics Instiute.


Dive into the research topics where Cancer Epigenetics Institute is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or